Migdal Insurance & Financial Holdings Ltd. Ptc Therapeutics, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$37.95 - $49.37 $401,169 - $521,890	-10,571 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$46.8 - $68.92 $307,008 - $452,115	6,560 Added 163.55%	10,571 $501,000
Q4 2020 Feb 08, 2021	BUY	$47.96 - $67.64 $192,367 - $271,304	4,011 New	4,011 $245,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$412 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$356 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$351 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$334 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$327 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.23B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account